Poster list

A detailed overview of all events can be found in the conference planner.

Filter
Code
Title
P001
Antimicrobial drug penetration in human abdominal abscesses
Poster flash presentation & Poster SSI
A. Cancela Costa Speaker Infectious Diseases Service and Microbiology Institute of Lausanne University Hospital (CHUV)A. Kritikos CHUV - University HospitalE. Glampedakis CHUV - University HospitalF. Grass CHUV - University HospitalE. Uldry CHUV - University HospitalC. Delabays CHUV - University HospitalF. Schaller CHUV - University HospitalJ. Pagani CHUV - University HospitalB. Guerry CHUV - University HospitalL. Decosterd CHUV - University HospitalF. Lamoth CHUV - University Hospital
P002
Evaluation of the 2023 Duke-ISCVID criteria for infective endocarditis in a multicenter cohort of patients with suspected infective endocarditis
Poster flash presentation & Poster SSI
M. Papadimitriou-Olivgeris Speaker Lausanne University Hospital and University of LausanneP. Monney Lausanne University Hospital and University of LausanneM. Frank University Hospital Zurich and University of ZurichG. Tzimas Lausanne University Hospital and University of LausanneP. Tozzi Lausanne University Hospital and University of LausanneM. Kirsch Lausanne University Hospital and University of LausanneM. Van Hemelrijck University Hospital Zurich and University of ZurichR. Bauernschmitt University Hospital Zurich and University of ZurichB. Guery Lausanne University Hospital and University of LausanneB. Hasse University Hospital Zurich and University of Zurich
P003
Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection
Poster flash presentation & Poster SSI
I. Abela Speaker Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, SwitzerlandC. Pasin Institute of Medical Virology, University of Zurich, SwitzerlandM. Schwarzmüller Institute of Medical Virology, University of Zurich, SwitzerlandA. Ulyte Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland T. Radtke Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland S. Haile Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland P. Ammann Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland S. Epp Institute of Medical Virology, University of Zurich, SwitzerlandC. Berger University Children Hospital Zurich, SwitzerlandJ. Böni Institute of Medical Virology, University of Zurich, SwitzerlandA. Manrique Institute of Medical Virology, University of Zurich, SwitzerlandA. Audigé Institute of Medical Virology, University of Zurich, SwitzerlandH. Michael Institute of Medical Virology, University of Zurich, SwitzerlandP. Schreiber Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, SwitzerlandT. Scheier Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, SwitzerlandJ. Fehr Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland J. Weber Institute of Medical Virology, University of Zurich, SwitzerlandP. Rusert Institute of Medical Virology, University of Zurich, SwitzerlandH. Günthard Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, SwitzerlandR. Kouyos Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, SwitzerlandM. Puhan Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland S. Kriemler Epidemiology, Biostatistics and Prevention Institute (EBPI),University of Zurich, Switzerland A. Trkola Institute of Medical Virology, University of Zurich, Switzerland
P004
Changes in the epidemiology of Streptococcus pyogenes infections before, during and after the COVID-19 pandemic in Switzerland
Poster flash presentation & Poster SSI
A. Cusini Speaker Abteilung für Infektiologie Kantonsspital GraubündenP. Sendi Institute for Infectious Diseases, University of Bern, SwitzerlandA. Kronenberg Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of Bern, Switzerland
P005
Two-year outcomes of treatment-experienced adults after programmatic transitioning from non-nucleoside reverse transcriptase inhibitor- to dolutegravir-based antiretroviral therapy: longitudinal data from an HIV cohort in Lesotho
Poster flash presentation & Poster SSI
N. Tschumi Speaker University Hospital BaselM. Lerotholi University Hospital BaselL. Motaboli SolidarMedM. Mokete SolidarMedJ. Brown University Hospital BaselN. Labhardt University Hospital Basel
P006
Increase of infective endocarditis due to viridans Streptococci among patients at moderate risk after change of guidance on antibiotic prophylaxis to prevent infective endocarditis: Results from a tertiary care referral centre in Switzerland
Poster flash presentation & Poster SSI
J. Epprecht Speaker USZB. Ledergerber USZM. Frank USZM. Greutmann USZM. Van Hemelrijck USZL. Ilcheva USZM. Padrutt USZB. Stadlinger USZM. Özcan UZHT. Carrel USZB. Hasse USZ
P007
Stem cell memory EBV-specific T cells control post-transplant lymphoproliferative disease and persist in vivo
Poster flash presentation & Poster SSI
D. Palianina Speaker University Hospital BaselJ. Mietz University of ZurichC. Stühler University Hospital BaselB. Arnold University Hospital BaselG. Bantug University Hospital BaselC. Münz University of ZurichO. Chijioke University of ZurichN. Khanna University Hospital Basel
P008
Routine infectious disease consultation prior to an allogeneic hematopoietic cell transplant.
Poster flash presentation & Poster SSI
V. Portillo Speaker HUGS. Masouridi-Levrat HUGY. Chalandon HUGM. Mappoura HUGS. Morin HUGM. Annalisa Hôpitaux fribourgeoisF. Giannotti HUGA. Mamez HUGC. van Delden HUGD. Neofytos HUG
P009
“False-positive” baseline CMV-serology in allogeneic hematopoietic cell transplant recipients
Poster flash presentation & Poster SSI
V. Portillo HUGS. Masouridi-Levrat HUGS. Masouridi-Levrat HUGY. Chalandon HUGL. Royston Speaker HUGM. Schibler HUGS. Yerly Ferrillo HUGM. Mappoura HUGS. Morin HUGF. Giannotti HUGA. Mamez HUGC. van Delden HUGD. Neofytos HUG
P010
An improved ex vivo rat model of Tick-borne encephalitis
Poster flash presentation & Poster SSI
S. Leoni Speaker Institute for Infectious Diseases, University of BernD. Grandgirard Institute for Infectious Diseases, University of BernS. Leib Institute for Infectious Diseases, University of Bern
P011
Invasive listeriosis in Southern Switzerland: a local problem that is actually global
Poster flash presentation & Poster SSI
M. Bongiovanni Speaker Ente Ospedaliero CantonaleB. Barda Ente Ospedaliero CantonaleG. Martinetti Lucchini Ente Ospedaliero CantonaleV. Gaia Ente Ospedaliero CantonaleG. Merlani Cantonal Service for Public Health, Bellinzona, SwitzerlandE. Bernasconi Ente Ospedaliero Cantonale
P012
Evolution of symptoms compatible with post-COVID condition after Wild-type infection and influence of Omicron BA.1 reinfection and SARS-CoV-2 vaccinations
Poster flash presentation & Poster SSI
C. Strahm Speaker Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyC. Kahlert Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyS. Guesewell Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyU. Besold Geriatric Clinic St. GallenE. Betschon Clienia Littenheid AG, Private Clinic for Psychiatry and PsychotherapyA. Brucher Psychiatry Services of the Canton of St. Gallen (South)A. Cusini Cantonal Hospital of Grisons, Division of Infectious DiseasesS. Goppel Psychiatry Services of the Canton of St. Gallen (North)A. McGeer Sinai Health System,C. Moeller Center for Neurological RehabilitationM. Ortner Rheintal Werdenberg Sarganserland Hospital GroupL. Risch Labormedizinisches Zentrum Dr Risch Ostschweiz AGM. Ruetti Fuerstenland Toggenburg Hospital GroupM. Schlegel Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyR. Stocker Hirslanden ClinicP. Vernazza Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyD. Vuichard-Gysin Thurgau Hospital Group, Division of Infectious Diseases and Hospital EpidemiologyB. Wiggli Cantonal Hospital Baden, Division of Infectious Diseases and Hospital EpidemiologyS. Kuster Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyP. Kohler Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology
P013
Aerosolization of Mycobacterium chelonae from heater-cooler-devices - a continuing risk of exposure during cardiac surgery
Poster flash presentation & Poster SSHH
S. Kuster Speaker Universitätsspital BaselS. Ragozzino Universitätsspital BaselM. von Rotz Universitätsspital BaselR. Kuehl Universitätsspital BaselG. Capoferri Universitätsspital BaselP. Urwyler Universitätsspital BaselT. Doebele Universitätsspital BaselF. Eckstein Universitätsspital BaselD. Goldenberger Universitätsspital BaselP. Schlaepfer Universitätsspital BaselS. Tschudin-Sutter Universitätsspital Basel
P014
Rectal carriage of multidrug-resistant organisms in healthcare personnel – a multicentre cross-sectional study
Poster flash presentation & Poster SSHH
T. Badinski Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St GallenS. Seiffert Division of Human Microbiology, Centre for Laboratory Medicine, St. GallenF. Grässli Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St GallenB. Babouee Flury Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St GallenU. Besold Geriatric Clinic St. GallenE. Betschon Clienia Littenheid AGA. Brucher Psychiatry Services of the Canton of St. GallenA. Cusini Division of Infectious Diseases, Cantonal Hospital of Grisons, ChurA. Egli Institute of Medical Microbiology, University of ZurichS. Goppel Psychiatry Services of the Canton of St. GallenJ. Keller Hirslanden Clinic ZurichM. von Kietzell Hirslanden Clinic StephanshornJ. Möller Center for Neurological Rehabilitation ZihlschlachtO. Nolte Division of Human Microbiology, Centre for Laboratory Medicine, St. GallenM. Ortner Sarganserland Rheintal Werdenberg Hospital Group, SwitzerlandM. Ruetti Fuerstenland Toggenburg Hospital Group, Wil, SwitzerlandM. Schlegel Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St GallenH. Seth-Smith Institute of Medical Microbiology, University of ZurichR. Stephan Section of Veterinary Bacteriology, Institute for Food Safety and Hygiene, University of ZurichR. Stocker Hirslanden Clinic ZurichD. Vuichard-Gysin Thurgau Hospital Group, Division of Infectious Diseases and Hospital Epidemiology, MuensterlingenB. Willi Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, ZurichS. Kuster Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St GallenC. Kahlert Children's Hospital of Eastern Switzerland, Department of Infectious Diseases and Hospital Epidemiology, St. GallenP. Kohler Speaker Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen
P015
The Challenges of Controlling Scabies in Asylum Centers: Lessons from the Canton of St. Gallen and Call for a Standardized National Approach
Poster flash presentation & Poster SSHH
M. Seneghini Speaker Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandA. Cozzio Department of Dermatology, Venereology and Allergology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.H. Gammeter Cantonal medical service, Canton St. Gallen, SwitzerlandS. Heim Trägerverein Integrationsprojekte St. GallenM. Koller State secretariat for Migration (SEM), BernS. Kuster Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandM. Schlegel Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandP. Schwarz Federal asylum center, Altstätten R. Tamò Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, SwitzerlandD. Flury Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
P016
The Infection Prevention and Control (IPC) Assessment Framework (IPCAF) questionnaire: Differing assessments within an infection control team?
Poster flash presentation & Poster SSHH
J. Männer Speaker Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyN. Bloch Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyP. Kohler Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital EpidemiologyM. Schlegel Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology
P017
Effective infection prevention and control measures in long-term care facilities in non-outbreak and outbreak settings – a systematic literature review
Poster flash presentation & Poster SSHH
N. Bloch Speaker Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandJ. Männer Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandC. Gardiol Federal Office of Public Health, Bern, SwitzerlandP. Kohler Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandJ. Kuhn Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandT. Münzer Geriatrische Klinik St. Gallen, St Gallen, Cantonal Hospital St Gallen, SwitzerlandM. Schlegel Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandS. Kuster Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandD. Flury Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland
P018
Screening and whole genome sequencing during an outbreak of Serratia marcescens in a neonatal and pediatric ICU
Poster flash presentation & Poster SSHH
A. Summerauer Speaker Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, SwitzerlandS. Egger Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, SwitzerlandS. Baars Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, SwitzerlandB. Ivàdy Department of Intensive Care and Neonatology, University Children's Hospital Zurich, SwitzerlandL. Schlapbach Department of Intensive Care and Neonatology, University Children's Hospital Zurich, SwitzerlandR. Stephan Institute for Food Safety and Hygiene University of Zurich, SwitzerlandC. Berger Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Switzerland
P019
Admission screening for multidrug resistant organisms (MRDO) in rehabilitation institutions: Is it worth it?
Poster flash presentation & Poster SSHH
J. Sumer Speaker Kantonsspital St. GallenK. Stiebeler Kantonsspital St. GallenP. Kohler Kantonsspital St. GallenC. Möller Center for Neurological Rehabilitation, ZihlschlachtS. Kuster Kantonsspital St. GallenM. Schlegel Kantonsspital St. Gallen
P020
Surveillance of outbreaks with respiratory viruses during the winter-season 2022/2023 in long-term-care facilities (LTCF) in Eastern Switzerland: Feasibility and first results from the OSKAR (Ostschweizer Kompetenznetz Infektionsprävention in Alters-und P
Poster flash presentation & Poster SSHH
N. Bloch Cantonal Hospital St. Gallen, Division of Infectious Disease and Hospital EpidemiologyJ. Kuhn Cantonal Hospital St. Gallen, Division of Infectious Disease and Hospital EpidemiologyS. Kuster Cantonal Hospital St. Gallen, Division of Infectious Disease and Hospital EpidemiologyP. Kohler Cantonal Hospital St. Gallen, Division of Infectious Disease and Hospital EpidemiologyM. Schlegel Cantonal Hospital St. Gallen, Division of Infectious Disease and Hospital EpidemiologyD. Flury Speaker Cantonal Hospital St. Gallen, Division of Infectious Disease and Hospital Epidemiology
P021
Experiences and Perspectives of Travelers and Health Professionals on Integrated Sexual Health Pre-travel Counseling in the Era of PrEP
Poster flash presentation & Poster SSTTM
N. Stürmer Speaker University of Zurich UZHM. Rasi University of Zurich UZHC. Moser University of Zurich UZHF. Sommer Stalder University of Zurich UZHJ. Giovanoli Evack University of Zurich UZHK. Siebenhuener University of Zurich UZHA. Anagnostopoulos University of Zurich UZHR. Novillo University of Zurich UZHA. van't Westeinde University of Zurich UZHO. Vrankovic Checkpoint ZurichB. Hampel University of Zurich UZH AND Checkpoint ZurichJ. Fehr University of Zurich UZHD. Nicca University of Zurich UZH
P022
Severe Case of Japanese Encephalitis after a short trip to Ubud in Bali
Poster flash presentation & Poster SSTTM
N. Hediger Nephrologie Kantonsspital GraubündenF. Porta Intensivstation Kantonsspital GraubündenA. Cusini Speaker Abteilung für Infektiologie Kantonsspital Graubünden
P023
RIVSEP: a retrospective study of vaccination in immunosuppressed MS patients
Poster flash presentation & Poster SSTTM
H. Buvelot Speaker HUGL. Carnino HUGR. Cordaillat HUGA. Poncet HUGF. Jacquerioz Bausch HUGJ. Schwob HUGP. Lalive HUGG. Eperon HUG
P024
“Same same but different” - visceral and complicated cutaneous leishmaniasis among lymphoma patients: a cases series
Poster flash presentation & Poster SSTTM
Y. Martin Speaker University Hospital of Bern (Inselspital)A. Eichenberger University Hospital of Bern (Inselspital)A. Frei University Hospital of Bern (Inselspital)T. Hübscher Praxis Inmitten von Bern, Tropen- und Reisemedizin, Innere MedizinU. Novak University Hospital of Bern (Inselspital)J. Blum Swiss Tropcial and Public Health Institute / University of BaselC. Staehelin University Hospital of Bern (Inselspital)
P025
Prevalence of infective endocarditis among patients with bacteraemia due to different streptococcal species
Poster (only) SSI
N. Fourré Speaker Lausanne University Hospital and University of LausanneV. Zimmermann Lausanne University Hospital and University of LausanneP. Monney Lausanne University Hospital and University of LausanneL. Senn Lausanne University Hospital and University of LausanneB. Guery Lausanne University Hospital and University of LausanneM. Papadimitriou-Olivgeris Lausanne University Hospital and University of Lausanne
P026
Dynamic of pediatric invasive bacterial infections in Switzerland before, during and after application of non-pharmaceutical interventions against COVID-19
Poster (only) SSI
M. Jaboyedoff Speaker Pediatric Infectious Diseases and Vaccinology Unit, Service of Pediatrics, Department Women-Mother-Child, Lausanne University Hospital and University of Lausanne, LausanneA. Niederer-Loher Division of Infectious Diseases and Hospital Epidemiology, Children's Hospital of Eastern Switzerland, St GallenC. Kahlert Division of Infectious Diseases and Hospital Epidemiology, Children's Hospital of Eastern Switzerland, St GallenP. Crisinel Pediatric Infectious Diseases and Vaccinology Unit, Service of Pediatrics, Department Women-Mother-Child, Lausanne University Hospital and University of Lausanne, LausanneF. Angoulvant Service of Pediatrics, Department Women-Mother-Child, Lausanne University Hospital and University of Lausanne, Lausanne
P027
Utilization of a Meningitis/Encephalitis PCR panel at the University Hospital Basel - a retrospective study to develop a testing algorithm
Poster (only) SSI
A. Erba Speaker University Hospital BaselF. Franzeck University Hospital BaselV. Hinic Institute of Medical Microbiology, University of ZurichA. Egli Institute of Medical Microbiology, University of ZurichM. Osthoff Speaker Winterthur Cantonal Hospital
P028
Cefepime versus carbapenems for treatment of AmpC beta-lactamase producing Enterobacterales bloodstream infections
Poster (only) SSI
J. Herrmann Speaker University Hospital Basel and University of BaselA. Burgener-Gasser University Hospital BaselD. Goldenberger University Hospital Basel and University of BaselJ. Roth University Hospital BaselM. Weisser University Hospital BaselP. Tamma Johns Hopkins University School of MedicineS. Tschudin-Sutter University Hospital Basel
P029
Automated Algorithm for the Detection of Obstetrical Sepsis in a Swiss tertiary care center
Poster (only) SSI
B. Tarasi Speaker CHUV LausanneJ. Despraz CHUV LausanneD. Baud CHUV LausanneT. Calandra CHUV LausanneS. Meylan CHUV Lausanne
P030
The Lausanne University Hospital Sepsis Quality of Care Program (LUHSQCP): accelerating recognition and optimizing care in a Swiss university tertiary care center.
Poster (only) SSI
S. Meylan Speaker CHUVR. Akrour CHUVJ. Despraz CHUVS. Nektarijevic CHUVR. Matusiak CHUVF. Bastardot CHUVA. Junger CHUVC. Galland-Decker CHUVO. Pignolet CHUVT. Niemi UNISANTEM. Le Pogam UNISANTES. Pepe CHUVL. Senn CHUVI. Lehn CHUVM. Roth CHUVT. Calandra CHUV
P031
Septris2.0 : An Updated, Free, Mobile, Online, Simulation Game That Improves Sepsis Recognition and Management
Poster (only) SSI
S. Meylan Speaker CHUV LausanneI. Pottmeyer StudioCypherN. Mischler StudioCypherL. Shieh Stanford University
P032
Financial significance of sepsis coding deficiencies for a tertiary center: The example of a cohort of patients brought in by ambulance for suspected infection
Poster (only) SSI
F. Agri CHUVD. Durr CHUVJ. Despraz CHUVT. Niemi UNISANTED. Fabrice CHUVM. Roth-Kleiner CHUVT. Calandra CHUVS. Meylan Speaker CHUV Lausanne
P034
Outcomes after switching from 144 weeks of blinded DTG/ABC/3TC or DTG+F/TAF to 96 weeks of open-label B/F/TAF
Poster (only) SSI
C. Orkin Queen Mary University of LondonA. Antinori Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani, RomeJ. Rockstroh Bonn University HospitalS. Moreno Guillén Hospital Universitario Ramón y CajalC. Martorell The Research InstituteJ. Molina Université de ParisA. Lazzarin San Raffaele HospitalF. Maggiolo Ospedale San GiovanniY. Yazdanpanah Bichat Hospital, Paris Descartes UniversityK. Andreatta Gilead Sciences, Inc.H. Huang Gilead Sciences, Inc.J. Hindman Gilead Sciences, Inc.H. Martin Gilead Sciences, Inc.T. Grabinger Speaker Gilead Sciences Switzerland SàrlJ. Baeten Gilead Sciences, Inc.A. Pozniak Chelsea and Westminster Hospital
P035
Infectious Disease Events after kidney re-transplantation compared to first kidney transplantation: data from the STCS
Poster (only) SSI
K. Kusejko Speaker UniversitätsSpital ZürichD. Neofytos University Hospital of GenevaH. Hirsch University of BaselP. Meylan University of LausanneK. Boggian KSSGC. Hirzel Inselspital - Universitätsspital BernC. Garzoni Clinica Luganese MoncuccoD. Sidler Inselspital - Universitätsspital BernA. Schnyder KSSGS. Schaub University Hospital BaselD. Golshayan Lausanne University HospitalF. Haidar University Hospital of GenevaM. Bonani University Hospital Zurich, Zurich, SwitzerlandR. Kouyos University Hospital ZurichN. Müller University Hospital ZurichP. Schreiber University Hospital Zurich
P036
Incidence and resistance rate of Pseudomonas aeruginosa bloodstream infections in Switzerland: a nationwide surveillance study (2008 – 2021)
Poster (only) SSI
A. Burri Speaker Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of BernL. Renggli Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of BernS. Ehrhard Emergency Department, Inselspital, University Hospital Bern and University of BernM. Gasser Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of BernA. Kronenberg Swiss Centre for Antibiotic Resistance (ANRESIS), Institute for Infectious Diseases, University of Bern
P037
Frequent HBsAg clearance during tenofovir therapy in HIV/HBV-coinfection
Poster (only) SSI
C. Béguelin Speaker Inselspital, Bern University HospitalE. Hofmann Inselspital, Bern University HospitalB. Surial Inselspital, Bern University HospitalA. Munting Lausanne University Hospital and University of LausanneH. Günthard University Hospital ZurichM. Stöckle University Hospital BaselE. Bernasconi Regional hospital of LuganoP. Schmid Cantonal Hospital of St. GallenA. Calmy Geneva University HospitalF. Suter-Riniker Institute for Infectious Diseases, University of Bern, SwitzerlandA. Rauch Inselspital, Bern University HospitalG. Wandeler Inselspital, Bern University Hospital
P038
Mycoplasma pneumoniae beyond the COVID-19 pandemic (ESGMAC MAPS study): out of office!
Poster (only) SSI
P. Meyer Sauteur Speaker University Children’s Hospital ZurichM. Beeton Cardiff Metropolitan UniversityM. ESGMAC European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC)
P039
Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults With HIV-1: Week 240 Results of the Phase 3 BRIGHTE Study
Poster (only) SSI
J. Aberg Icahn School of Medicine at Mount Sinai, New York, NY, USAB. Shepherd GSK, Brentford, UKM. Wang GSK, Collegeville, PA, USAJ. Madruga CRT-DST/AIDS SP, São Paulo, BrazilF. Urbina Hospital Nacional Edgardo Rebagliati Martins, Lima, PeruC. Katlama AP-HP, Hôpital Pitié-Salpêtrière, Service de Maladies Infectieuses et Tropicales, INSERM-Sorbonne Universités, Paris, FranceS. Schrader Schrader Clinic, Houston, TX, USAJ. Eron University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USAS. Chabria ViiV Healthcare, Branford, CT, USAA. Clark ViiV Healthcare, Brentford, UKA. Pierce ViiV Healthcare, Durham, NC, USAM. Lataillade ViiV Healthcare, Branford, CT, USAP. Ackerman ViiV Healthcare, Branford, CT, USAM. Mika Speaker ViiV Healthcare, Münchenbuchsee, Switzerland
P040
Professional practices and factors associated with antibiotic prescription for lower respiratory tract infections in nursing homes
Poster (only) SSI
A. Roux Speaker Infectious Diseases Service, Lausanne University HospitalD. Vu Communicable disease unit, Division of General cantonal physician, Geneva Directorate of Health; Pediatric Infectious Diseases Unit, Department of Woman, Child and Adolescent, University Hospitals of GenevaA. Niquille Center for Primary Care and Public Health (Unisanté), Pharmacy, University of LausanneE. Rubli Geriatric Medicine and Geriatric Rehabilitation Division, Lausanne University Hospital T. Bizzozzero Department of Internal Medicine and Geriatrics, Morges HospitalA. Tahar Division of Internal Medicine for the Aged, Department of Rehabilitation and Geriatrics, Geneva University HospitalsT. Morlan Division of Internal Medicine for the Aged, Department of Rehabilitation and Geriatrics, Geneva University HospitalsD. Akpokavie Internal Medicine department, Trois Chênes HospitalM. Gandin Faculty of Medicine, University of GenevaA. Merkly Faculty of Medicine, University of GenevaA. Cassini Cantonal Doctor Office, Public Health Department, Canton of Vaud; Infection Prevention and Control Unit, Infectious Diseases Service, Lausanne University HospitalE. Glampedakis Cantonal Doctor Office, Public Health Department, Canton of Vaud; Infection Prevention and Control Unit, Infectious Diseases Service, Lausanne University HospitalN. Boillat-Blanco Infectious Diseases Service, Lausanne University Hospital
P041
Increase of invasive and probable invasive group A Streptococcal infections in adults in the cantonal hospital of Grisons, Switzerland
Poster (only) SSI
A. Schweighauser Intensivmedizin Kantonsspital GraubündenF. Porta Intensivmedizin Kantonsspital GraubündenA. Wäckerlin Intensivmedizin Kantonsspital GraubündenM. Kajdi-Schwab Intensivmedizin Kantonsspital GraubündenF. Marti Abteilung für Infektiologie Kantonsspital GraubündenR. Capaul Mikrobiologie Kantonsspital GraubündenA. Cusini Speaker Abteilung für Infektiologie Kantonsspital Graubünden
P042
Effect of photodynamic therapy on skin microbiome (PHOMIC-III)
Poster (only) SSI
T. Schweizer Speaker Department of Dermatology, University Hospital Zurich, University of ZurichJ. Würmli Department of Dermatology, University Hospital Zurich, University of ZurichH. Koliwer-Brandl Institute of Medical Microbiology, University of ZurichA. Egli Institute of Medical Microbiology, University of ZurichL. Imhof Department of Dermatology, University Hospital Zurich, University of ZurichP. Bosshard Department of Dermatology, University Hospital Zurich, University of ZurichY. Achermann Department of Dermatology, University Hospital Zurich, University of Zurich and Department of Internal Medicine, Hospital Zollikerberg
P043
Cessation of antivirale treatment in chronic hepatitis B Expirience of a small center
Poster (only) SSI
R. Piso Speaker Kantonsspital OltenM. Hoffmann Kantonsspital Olten
P044
Validation of sTREM-1 and IL-6 based algorithms for outcome prediction of COVID-19
Poster (only) SSI
M. Van Singer Speaker Infectious Diseases Service of Lausanne University Hospital (CHUV)T. Brahier Infectious Diseases Service of Lausanne University Hospital (CHUV)J. Koch Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St.Gallen, St.GallenO. Hugli Emergency Department, University Hospital of Lausanne, SwitzerlandA. Weckman Tropical Disease Unit, Department of Medicine, University of Toronto, Sandra Rotman Centre for Global Health, University Health Network-Toronto General, Toronto, Ontario, CanadaK. Zhong Tropical Disease Unit, Department of Medicine, University of Toronto, Sandra Rotman Centre for Global Health, University Health Network-Toronto General, Toronto, Ontario, CanadaT. Kain Tropical Disease Unit, Department of Medicine, University of Toronto, Sandra Rotman Centre for Global Health, University Health Network-Toronto General, Toronto, Ontario, CanadaA. Leligdowicz Tropical Disease Unit, Department of Medicine, University of Toronto, Sandra Rotman Centre for Global Health, University Health Network-Toronto General, Toronto, Ontario, CanadaE. Bernasconi Division of infectious diseases, Ente Ospedaliero Cantonale, Lugano, University of Geneva and University of Southern Switzerland, Lugano, SwitzerlandA. Ceschi Division of infectious diseases, Ente Ospedaliero Cantonale, Lugano, University of Geneva and University of Southern Switzerland, Lugano, SwitzerlandK. Kain Tropical Disease Unit, Department of Medicine, University of Toronto, Sandra Rotman Centre for Global Health, University Health Network-Toronto General, Toronto, Ontario, CanadaW. Albrich Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St.Gallen, St.GallenN. Boillat-Blanco Infectious Diseases Service of Lausanne University Hospital (CHUV)
P045
Parvimonas micra, a new potential pathogen in hospitalized patients: a case series from 2015-2022
Poster (only) SSI
E. Bernasconi Ente Ospedaliero CantonaleD. Piccinini Ente Ospedaliero CantonaleC. Di Benedetto Ente Ospedaliero CantonaleG. Martinetti Lucchini Ente Ospedaliero CantonaleB. Barda Ente Ospedaliero CantonaleM. Bongiovanni Speaker Ente Ospedaliero Cantonale
P046
Quantifying sepsis awareness in neonatal units in Switzerland Neonatal Sepsis Awareness for Education (neoSAfE)
Poster (only) SSI
N. Asper University of BernM. Moser CHUVF. Rosa Mangeret HUGM. Stocker Kantonspital LuzernM. Schuler Barazzoni CHUVE. Giannoni CHUVS. Meylan Speaker CHUV Lausanne
P047
Implementation of a multidisciplinary meeting improves communication between surgeons and infectious diseases specialists who manage complicated intra-abdominal infections
Poster (only) SSI
F. Desgranges Speaker University Hospital (CHUV) and University of LausanneT. Favre-Bulle University Hospital (CHUV) and University of LausanneE. Melloul University Hospital (CHUV) and University of LausanneN. Halkic University Hospital (CHUV) and University of LausanneE. Jaccard University Hospital (CHUV) and University of LausanneB. Guery University Hospital (CHUV) and University of LausanneE. Uldry University Hospital (CHUV) and University of Lausanne
P048
Prevalence of Antibiotic Resistance among Urinary Tract Infections caused by Escherichia coli in Patients from rural Tanzania – Implications for Empirical Antibiotic Treatment Guidelines
Poster (only) SSI
M. Macha Speaker Kantonsspital St. Gallen KSSG and St. Francis University College of Health and Allied Sciences, TanzaniaA. Bösch Kantonsspital St. Gallen KSSGH. Urassa St.Francis Referral Hospital, Ifakara, TanzaniaW. Qi Functional Genomics Center Zurich, University of ZurichS. Seiffert Division of Human Microbiology, Centre for Laboratory Medicine, St. GallenS. Haller Kantonsspital St. Gallen KSSGP. Kohler Kantonsspital St. Gallen KSSGM. Weisser Rohacek University and University Hospital BaselB. Babouee Flury Kantonsspital St. Gallen KSSG
P049
Outcome of surgical treatment strategies for spinal infections: a retrospective cohort study
Poster (only) SSI
S. Haubitz Speaker Kantonsspital Aarau F. Frank Kantonspital Aarau / Oxford University Hospitals, Oxford, UKA. Mallisho Pain Center, Kunstmuseum Basel AG, BaselM. Jäger Kantonsspital Aarau A. Conen Kantonspital Aarau
P050
Impact of Multidisciplinary Endocarditis Team on management of infective endocarditis
Poster (only) SSI
V. Zimmermann Speaker Lausanne University Hospital and University of LausanneN. Fourré Lausanne University Hospital and University of LausanneB. Guery Lausanne University Hospital and University of LausanneP. Tozzi Lausanne University Hospital and University of LausanneM. Kirsch Lausanne University Hospital and University of LausanneP. Monney Lausanne University Hospital and University of LausanneM. Papadimitriou-Olivgeris Lausanne University Hospital and University of Lausanne
P051
Lenacapavir with bNAbs GS-5423 and GS-2872 dosed every 6 months in people with HIV
Poster (only) SSI
J. Eron University of North CarolinaS. Little University of CaliforniaG. Crofoot CrofootMD Clinic and Research CenterP. Cook East Carolina UniversityP. Ruane Ruane Clinical Research GroupD. Jayaweera University of Miami, Miller School of MedicineE. DeJesus Orlando Immunology CenterS. Waldman University of California, DavisM. Mehrotra Gilead Sciences, Inc.L. VanderVeen Gilead Sciences, Inc.H. Huang Gilead Sciences, Inc.S. Collins Gilead Sciences, Inc.T. Grabinger Speaker Gilead SciencesJ. Baeten Gilead Sciences, Inc.M. Caskey Rockefeller University
P052
Efficacy and safety of long-acting subcutaneous lenacapavir in heavily treatment-experienced people with multi-drug resistant HIV: Week 52 results
Poster (only) SSI
O. Ogbuagu Yale UniversityS. Segal-Maurer New York Presbyterian QueensW. Ratanasuwan Siriraj Hospital, Mahidol UniversityB. Trottier Clinique de Médecine Urbaine du Quartier LatinJ. Brunetta Maple Leaf ResearchT. Shirasaka Osaka National HospitalE. Koenig Instituto de Estudios VirologicosH. Wang Gilead Sciences, Inc.N. Margot Gilead Sciences, Inc.H. Dvory-Sobol Gilead Sciences, Inc.M. Rhee Gilead Sciences, Inc.C. Oberle Speaker Gilead Sciences Switzerland SàrlJ. Baeten Gilead Sciences, Inc.J. Molina INSERM, Université Sorbonne Paris Cité
P053
A Knowledge-Graph to support Sepsis Care in a Tertiary University Center
Poster (only) SSI
J. Despraz Speaker CHUV - Hôpital universitaireR. Matusiak CHUV LausanneS. Nektarijevic CHUV LausanneV. Rossetti EPFLJ. Raisaro CHUV LausanneS. Meylan CHUV Lausanne
P054
Superinfections in hospitalized COVID 19 patients (SUPER Covid-19): data from the multicentric retrospective CH-SUR cohort study of hospitalized COVID-19 patients in Switzerland
Poster (only) SSI
G. Scanferla Speaker Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, SwitzerlandA. Blöchlinger Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, SwitzerlandV. Bättig Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, SwitzerlandM. Büttcher Cantonal Hospital of Lucerne, Children’s Hospital, Pediatric Infectious Diseases, Lucerne, SwitzerlandA. Cusini Department of General Medicine, Cantonal Hospital of Grisons, Chur, SwitzerlandA. Iten Service of Prevention and Infection Control, Directorate of Medicine and Quality, University Hospital Geneva, Geneva, SwitzerlandO. Keiser Institute of Global Health, CAMPUS BIOTECH, Geneva, SwitzerlandR. Sommerstein Faculty of Health Sciences and Medicine, Clinic St. Anna, University of Lucerne, Lucerne, SwitzerlandJ. Sobel Institute of Global Health, CAMPUS BIOTECH, Geneva, SwitzerlandW. Albrich Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland
P055
Clinical relevance of HIV low-level viremia in the dolutegravir era: data from the Viral Load Cohort North-East Lesotho (VICONEL)
Poster (only) SSI
M. Kohler Speaker University and University Hospital Basel, Basel, SwitzerlandJ. Brown University and University Hospital Basel, Basel, SwitzerlandN. Tschumi University and University Hospital Basel, Basel, SwitzerlandM. Lerotholi University and University Hospital Basel, Basel, SwitzerlandL. Motaboli SolidarmedM. Mokete SolidarmedF. Chammartin University and University Hospital Basel, Basel, SwitzerlandN. Labhardt University and University Hospital Basel, Basel, Switzerland
P056
P057
Low Rilpivirine levels in oral lead-in phase in patients with gastric bypass
Poster (only) SSI
R. Piso Speaker Kantonsspital OltenM. Hoffmann Kantonsspital OltenL. Decosterd CHUV - Hôpital universitaireP. Thoueille CHUV - Hôpital universitaire
P058
Evaluation of the new Oxford Nanopore Technologies V14 kit for routine genomic sequencing and genomic epidemiology in the clinical setting
Poster (only) SSI
S. Neuenschwander Speaker University of Bern, Insitute for Infectious DiseasesL. Stauber University of Bern, Insitute for Infectious DiseasesM. Terrazos Miani University of Bern, Insitute for Infectious DiseasesS. Gempeler University of Bern, Insitute for Infectious DiseasesS. Leib University of Bern, Insitute for Infectious DiseasesC. Casanova University of Bern, Insitute for Infectious DiseasesA. Ramette University of Bern, Insitute for Infectious Diseases
P059
Comparison of Telomere Length Changes Over 48 Weeks in SALSA Study: DTG/3TC vs CAR
Poster (only) SSI
M. Underwood ViiV Healthcare, Durham, NCJ. Oyee GSK, Brentford, UKJ. Horton Parexel International, Durham, NC, USAT. Chakraborty GSK, Bangalore, IndiaC. Parry ViiV Healthcare, Brentford, UKR. Wang ViiV Healthcare, Durham, NCJ. Lin University of California, San Francisco, CA, USAM. Sithamparanathan ViiV Healthcare, Brentford, UKB. Jones ViiV Healthcare, Brentford, UKB. Wynne ViiV Healthcare, Durham, NC, USAC. Man ViiV Healthcare, Durham, NC, USAA. Zolopa ViiV Healthcare, Durham, NC, USAT. Edinger Speaker ViiV Healthcare
P060
Results at 12 months post-vaccination with a respiratory syncytial virus (RSV) prefusion F protein investigational vaccine (RSVPREF3 OA)
Poster (only) SSI
P. Runge Speaker GSK Pharma SchweizT. Schwarz Klinikum Würzburg Mitte, Campus Juliusspital, Würzburg, GermanyS. Hwang En Chu Kong Hospital, New Taipei City, Taipei Veterans General Hospital, and National Yang Ming Chiao Tung University School of Medicine, Taipei, TaiwanP. Ylisastigui Alliance For MultiSpecialty Research, Fort Myers, United StatesC. Liu China Medical University Hospital, Taichung, TaiwanK. Takazawa Medical Corporation Shinanokai, Shinanozaka Clinic, Tokyo, JapanM. Yono Nishi-Kumamoto Hospital, Kumamoto, JapanJ. Ervin The Alliance for Multispecialty Research, Kansas City, United StatesC. Andrews IMA Research San Antonio, Texas, United StatesC. Fogarty Spartanburg Medical Research, South Carolina, United StatesT. Eckermann Praxis Dr. med. Irmgard Maier-Bosse, Munich, GermanyD. Collete GSK, Rixensart, BelgiumM. de Heusch GSK, Wavre, BelgiumN. De Schrevel GSK, Rixensart, BelgiumB. Salaun GSK, Rixensart, BelgiumA. Lambert GSK, Wavre, BelgiumC. Maréchal GSK, Wavre, BelgiumP. Nakanwagi GSK, Wavre, BelgiumM. Lievens GSK, Wavre, BelgiumV. Hulstrøm GSK, Wavre, Belgium
P061
Durable Efficacy of Switching From a 3-/4-Drug Tenofovir Alafenamide (TAF)-Based Regimen to the 2-Drug Regimen Dolutegravir/Lamivudine (DTG/3TC) in the TANGO Study Through Week 196
Poster (only) SSI
S. De Wit CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, BelgiumF. Bonnet CHU de Bordeaux, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, FranceO. Osiyemi Triple O Research Institute PA, West Palm Beach, FL, USAF. Bisshop Holdsworth House Medical Brisbane, Queensland, AustraliaJ. Olalla Unidad de Medicina Interna, Hospital Costa del Sol, Marbella, SpainJ. Routy McGill University Health Centre, Montreal, QC, CanadaC. Wyen Praxis am Ebertplatz, Cologne, GermanyR. Moodley ViiV Healthcare, Brentford, UKK. Pappa ViiV Healthcare, Durham, NC, USAR. Wang ViiV Healthcare, Durham, NC, USAJ. Oyee GSK, Brentford, UKP. Saggu GSK, Brentford, UKE. Letang ViiV Healthcare, Madrid, SpainB. Wynne ViiV Healthcare, Durham, NC, USAB. Jones ViiV Healthcare, Brentford, UKK. Smith ViiV Healthcare, Durham, NC, USAM. Ait-Khaled ViiV Healthcare, Brentford, UKM. Mika Speaker ViiV Healthcare, Münchenbuchsee, Switzerland
P062
Characterisation of acute and recent HIV infection in Zurich: a cohort update of the Zurich Primary HIV Infection study
Poster (only) SSI
C. Tallon de Lara Speaker University Hospital ZurichM. Freind Speaker University Hospital ZurichD. Braun Speaker University Hospital ZurichH. Guenthard University Hospital ZurichD. Wimmersberger University Hospital ZurichH. Kuster University Hospital ZurichB. Hampel Checkpoint ZurichC. Grube Checkpoint ZurichL. Aceto City Hospital of ZurichA. Schibli City Hospital of ZurichH. Kovari Hirslanden Klinik im ParkM. Flepp Hirslanden Klinik im Park
P063
Performance of serological scores to detect liver steatosis among people with HIV
Poster (only) SSI
C. Riebensahm Speaker Inselspital, Bern University Hospital, University of Bern, SwitzerlandJ. Brocker Inselspital, Bern University Hospital, University of Bern, SwitzerlandA. Berzigotti Inselspital, Bern University Hospital, University of Bern, SwitzerlandH. Günthard University Hospital Zurich, University of Zurich P. Tarr Kantonsspital Bruderholz, University of Basel H. Furrer Inselspital, Bern University Hospital, University of Bern, SwitzerlandA. Rauch Inselspital, Bern University Hospital, University of Bern, SwitzerlandG. Wandeler Inselspital, Bern University Hospital, University of Bern, SwitzerlandB. Surial Inselspital, Bern University Hospital, University of Bern, Switzerland
P064
Performance of vital signs, clinical prediction rule and biomarkers as predictors of radiological pneumonia and hospital admission in primary care versus emergency department settings
Poster (only) SSI
A. Roux Speaker Infectious Diseases Service, Lausanne University HospitalT. Brahier Infectious Diseases Service, Lausanne University HospitalJ. Knüsli Infectious Diseases Service, Lausanne University HospitalL. Lhopitallier Gare 10 Lausanne General PracticeC. Fischer Faculty of Medicine, University of Lausanne Y. Mueller Department of Family Medicine, Centre for Primary Care and Public Health (Unisanté), University of LausanneN. Senn Department of Family Medicine, Centre for Primary Care and Public Health (Unisanté), University of LausanneA. Kronenberg Institute for Infectious Diseases, University of BernD. Rotzinger Department of Diagnostic and Interventional Radiology, Lausanne University Hospital E. Tenisch Department of Diagnostic and Interventional Radiology, Lausanne University Hospital O. Hugli Emergency Department, Lausanne University Hospital K. Kain Tropical Disease Unit, Department of Medicine, University of TorontoN. Boillat-Blanco Infectious Diseases Service, Lausanne University Hospital
P065
Late re-engagement into HIV care among adults in the Swiss HIV Cohort Study
Poster (only) SSI
A. Haas Speaker University of Bern, Bern, SwitzerlandK. Kusejko University of Zurich, Zurich, SwitzerlandM. Cavassini University Hospital of Lausanne, University of Lausanne, Lausanne, SwitzerlandH. Günthard University Hospital Zurich, University of Zurich, Zurich, SwitzerlandM. Stöckle University Hospital Basel, University of Basel, Basel, SwitzerlandA. Calmy Geneva University Hospital, University of Geneva, Geneva, SwitzerlandE. Bernasconi Regional Hospital of Lugano, Lugano, SwitzerlandP. Schmid Cantonal Hospital of St Gallen, St Gallen, SwitzerlandA. Rauch Bern University Hospital, University of Bern, Bern, SwitzerlandM. Egger University of Bern, Bern, SwitzerlandG. Wandeler Bern University Hospital, University of Bern, Bern, Switzerland
P066
Macrophages show unprecedented anti-HIV activity in HIV-infected iHMD-NSG mice
Poster (only) SSI
L. Baroncini Speaker University Hospital ZurichC. Müller University Hospital ZurichN. Kadzioch University Hospital ZurichR. Wolfensberger University Hospital ZurichT. Mlambo University Hospital ZurichS. Bredl University Hospital ZurichS. Bredl University Hospital ZurichR. Speck University Hospital Zurich
P067
Group A Streptococcus antibiotic tolerance in necrotizing fasciitis
Poster (only) SSI
N. Keller University Hospital ZurichM. Boumasmoud University Hospital ZurichF. Andreoni Speaker University Hospital ZurichA. Tarnutzer University Hospital ZurichM. von Matt University Hospital ZurichT. Scheier University Hospital ZurichJ. Epprecht University Hospital ZurichA. Gomez-Mejia University Hospital ZurichM. Huemer University Hospital ZurichE. Marques-Maggio University Hospital ZurichR. Schuepbach University Hospital ZurichS. Mairpady-Shambat University Hospital ZurichS. Brugger University Hospital ZurichA. Zinkernagel University Hospital Zurich
P068
Viewpoint: Implementation of recommendations for rational use of proton pump inhibitors (PPI) and antibiotics in the treatment of Helicobacter pylori (HP) infection
Poster (only) SSI
R. Weber Speaker mediX Altstetten und Universität ZurichJ. Borovicka Kantonsspital St. GallenS. Bosshard Central-Praxis AG, ZürichS. Brugger Universitätsspital & Universität ZürichE. Colin-Benoit Inselspital BernA. Egli Universität ZürichF. Imkamp Universität ZürichP. Keller Universität BernB. Müllhaupt Universitätsspital ZürichA. Plate Universitätsspital & Universität ZürichC. Chmiel Wissenschaft mediX Schweiz und mediX Praxis Friesenberg ZürichS. Kuster Kantonsspital St. Gallen
P069
An unexpected culprit of cervical Spondylitis
Poster (only) SSI
C. Gutmann Speaker Division of Infectious DiseasesA. Meyer Division of Internal MedicineA. Andrees Division of Internal MedicineV. Bansal Division of Infectious DiseasesU. Karrer Division of Infectious Diseases
P070
To die with or to die for COVID-19 infection: what 2022 has taught us
Poster (only) SSI
M. Bongiovanni Speaker Ente Ospedaliero CantonaleS. Simon Ente Ospedaliero CantonaleB. Barda Ente Ospedaliero CantonaleG. Martinetti Lucchini Ente Ospedaliero CantonaleC. Di Benedetto Ente Ospedaliero CantonaleG. Merlani Cantonal Service for Public Health, Bellinzona, SwitzerlandE. Bernasconi Ente Ospedaliero Cantonale
P071
Performance of an HAV IgG rapid test from capillary whole-blood in Swiss opioid agonist therapy (OAT) patients
Poster (only) SSI
A. Bregenzer Speaker Department of Infectious Diseases and Infection Prevention, Cantonal Hospital AarauS. Eichhorn Department of Infectious Diseases and Infection Prevention, Cantonal Hospital AarauP. Rippstein Outpatient Centre of Substitution Therapy HAG, Department of Addictive Disorders, Psychiatric Services Aargau, BruggM. Oberle Institute for Laboratory Medicine, Cantonal Hospital AarauC. Fux Department of Infectious Diseases and Infection Prevention, Cantonal Hospital Aarau
P072
B-free trial: Booster-free antiretroviral therapy for persons living with HIV and multidrug resistance
Poster (only) SSI
M. Ballif Speaker Universitätsklinik für Infektiologie, Inselspital, BernA. Limacher Clinical Trial Unit, University of BernM. Correia da Silva Saúde Universitätsklinik für Infektiologie, Inselspital, BernD. Braun USZ UniversitätsSpital ZürichA. Calmy HUG Hôpitaux Universitaires de GenèveR. Kouyos USZ UniversitätsSpital ZürichE. Bernasconi Ospedale Regionale di LuganoM. Cavassini CHUV Centre Hospitalier Universitaire VaudoisM. Stoeckle Universitätsspital BaselP. Schmid Kantonsspital St. Gallen KSSGD. Haerry Positivrat Schweiz, Le Conseil Positif Suisse, ZürichH. Günthard USZ UniversitätsSpital ZürichA. Rauch Universitätsklinik für Infektiologie, Inselspital, BernB. Surial Universitätsklinik für Infektiologie, Inselspital, BernG. Wandeler Universitätsklinik für Infektiologie, Inselspital, Bern
P073
Rapid and Sensitive Single-Sample Viral Metagenomics using Nanopore Flongle Sequencing
Poster (only) SSI
I. Pichler University of ZurichS. Schmutz University of ZurichG. Ziltener University of ZurichM. Zaheri University of ZurichV. Kufner University of ZurichA. Trkola University of ZurichM. Huber Speaker University of Zurich
P074
Buprenorphine analgesia is influencing several reading outcomes in experimental pneumococcal meningitis
Poster (only) SSI
D. Grandgirard Speaker University of Bern, Insitute for Infectious DiseasesS. Leib University of Bern, Insitute for Infectious Diseases
P075
Absence of proviral HIV-1 evolution in early treated individuals with HIV-1 switching to dolutegravir monotherapy during 48 weeks
Poster (only) SSI
L. Jörimann Speaker Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandJ. Tschum Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandM. Zeeb Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandC. Leemann Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandC. Schenkel Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandK. Neumann Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandS. Chaudron Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandM. Zaheri Institute of Medical Virology (IMV), University of Zurich (UZH)P. Frischknecht Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandN. Neuner-Jehle Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandH. Kuster Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandD. Braun Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandC. Grube Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandR. Kouyos Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandK. Metzner Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandH. Günthard Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
P076
Efficacy and safety at 96 weeks of bulevirtide 2 mg or 10 mg monotherapy for chronic hepatitis D: results from an interim analysis of a phase 3 randomized study
Poster (only) SSI
H. Wedemeyer Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule HannoverS. Aleman Karolinska University Hospital/Karolinska InstitutetM. Brunetto Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa; Department of Clinical and Experimental Medicine, University of PisaA. Blank Heidelberg University HospitalP. Andreone University of Modena and Reggio Emilia, Internal Medicine, Baggiovara HospitalP. Bogomolov State Budgetary Institution of Health Care of Moscow Region “Moscow Regional Research Clinical Institute After M.F. Vladimirsky”V. Chulanov FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian Federation; Sechenov UniversityN. Mamonova FSBI National Research Medical Center for Phthisiopulmonology and Infectious Diseases of the Ministry of Health of the Russian FederationN. Geyvandova Stavropol Regional HospitalV. Morozov LLC Medical Company “Hepatolog"O. Sagalova Southern Ural State Medical UniversityT. Stepanova Clinic of Modern MedicineC. Oberle Speaker Gilead Sciences, Inc.D. Manuilov Gilead Sciences, Inc.R. Mercier Gilead Sciences, Inc.Q. An Gilead Sciences, Inc.J. Flaherty Gilead Sciences, Inc.A. Osinusi Gilead Sciences, Inc.A. Lau Gilead Sciences, Inc.J. Schulze zur Wiesch Universitätsklinikum Hamburg-Eppendorf Medizinische Klinik Studienambulanz HepatologieM. Cornberg Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule HannoverS. Zeuzem University Hospital Frankfurt, Department of MedicineP. Lampertico Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Division of Gastroenterology and Hepatology; CRC “A. M. and A. Migliavacca” Center for Liver Disease, University of Milan, Department of Pathophysiology and Transplantation
P078
No safety concerns observed when the adjuvanted recombinant zoster vaccine (RZV) and the COVID-19 mRNA-1273 booster were co-administered in ≥50-year-olds
Poster (only) SSI
A. Naficy GSK, Rockville, MD, United StatesP. Pirrotta GSK, Wavre, BelgiumJ. Miller Clinical Development, Moderna, Inc., Cambridge, MA, United StatesB. Leav Clinical Development, Moderna, Inc., Cambridge, MA, United StatesA. Mwakingwe-Omari GSK, Rockville, MD, United StatesP. Runge Speaker GSK Pharma Schweiz
P079
Capnocytophaga canimorsus diagnosis in peripheral blood smear: A case report and literature review
Poster (only) SSI
V. Gisler Speaker Kantonsspital Aarau AGN. Hunn Kantonsspital Aarau AGJ. Caflisch Kantonsspital Aarau AGM. Bader Kantonsspital Aarau AGE. Hitz Kantonsspital Aarau AGH. Fankhauser Kantonsspital Aarau AGB. Jakopp Kantonsspital Aarau AGL. Cioccari Kantonsspital Aarau AGA. Conen Kantonsspital Aarau AGC. Fux Kantonsspital Aarau AGM. Oberle Kantonsspital Aarau AG
P080
Diagnostic performance of the hepatitis C virus core antigen (HCVcAg) test in serum samples from the canton Aargau and a subgroup of psychiatric in- and outpatients
Poster (only) SSI
A. Bregenzer Speaker Department of Infectious Diseases and Infection Prevention, Cantonal Hospital AarauD. Hillmann Laboratory Dr. RischM. Risch Laboratory Dr. RischT. Lung Laboratory Dr. RischN. Wohlwend Laboratory Dr. RischL. Risch Laboratory Dr. RischE. Pichler Department of Addictive Disorders, Psychiatric Services Aargau, BruggD. Gurrea Salas Department of Addictive Disorders, Psychiatric Services Aargau, BruggC. Fux Department of Infectious Diseases and Infection Prevention, Cantonal Hospital Aarau
P081
Predicting Dolutegravir resistance in Southern Africa: the DTG MARISA model
Poster (only) SSI
T. Loosli Speaker Universitätsspital Zurich, University of ZurichA. Hauser Universitätsspital Zurich, University of ZurichJ. Josi Universitätsspital Zurich, University of ZurichN. Han Universitätsspital Zurich, University of ZurichR. Lessells University of KwaZulu-NatalH. Günthard Universitätsspital Zurich, University of ZurichM. Egger University of BernR. Kouyos Speaker Universitätsspital Zurich, University of Zurich
P082
HEV seroprevalence and infection incidence in a contemporary Swiss cohort of HCT recipients
Poster (only) SSI
J. Courjon Speaker HUG Hôpitaux Universitaires de GenèveV. Portillo HUG Hôpitaux Universitaires de GenèveS. Masouridi HUG Hôpitaux Universitaires de GenèveY. CHALANDON HUG Hôpitaux Universitaires de GenèveM. MAPPOURA HUG Hôpitaux Universitaires de GenèveS. MORIN HUG Hôpitaux Universitaires de GenèveF. GIANNOTTI HUG Hôpitaux Universitaires de GenèveA. MAMEZ HUG Hôpitaux Universitaires de GenèveS. YERLY FERRILLO HUG Hôpitaux Universitaires de GenèveM. Schibler HUG Hôpitaux Universitaires de GenèveC. van Delden HUG Hôpitaux Universitaires de GenèveD. Neofytos HUG Hôpitaux Universitaires de Genève
P083
CMV-IgG level pre-allogeneic hematopoietic cell transplantation in patients receiving letermovir is not associated with breakthrough infections nor reactivations
Poster (only) SSI
L. Royston Speaker Hôpitaux Universitaires de GenèveL. Chavaz Hôpitaux Universitaires de GenèveV. Portillo Hôpitaux Universitaires de GenèveE. Royston Hôpitaux Universitaires de GenèveS. Masouridi-Levrat Hôpitaux Universitaires de GenèveY. Chalandon Hôpitaux Universitaires de GenèveC. Van Delden Hôpitaux Universitaires de GenèveD. Neofytos Hôpitaux Universitaires de Genève
P084
Case report on a rare cause of a vascular graft infection
Poster (only) SSI
K. Marinakis Speaker Kantonsspital WinterthurA. Meyer Kantonsspital WinterthurU. Karrer Kantonsspital WinterthurA. Schmid Speaker Kantonsspital Winterthur
P085
Extraneurological Manifestations of Tick-borne Encephalitis Virus: Report of a Rare Case of TBE-associated Myocarditis and Review of the Literature
Poster (only) SSI
M. Seneghini Speaker Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandF. Lugano Division of Internal Medicine, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandM. Maeder Division of Cardiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandR. Garcia-Boy Division of Human Immunology, Center for Laboratory Medicine, St. Gallen, SwitzerlandC. Strahm Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland
P086
Severe community-acquired pneumococcal ventriculitis as a complication of otogenic pneumococcal meningitis - a case report
Poster (only) SSI
M. Seneghini Speaker Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandJ. Deppe Division of Neurology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandP. Balcerak Division of Neurology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandG. Kägi Division of Neurology, Cantonal Hospital of St. Gallen, St. Gallen, SwitzerlandW. Albrich Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital of St. Gallen, St. Gallen, Switzerland
P087
The estimated burden of Sepsis in Switzerland over the 2009-2017 period
Poster (only) SSI
M. Le Pogam UNISANTET. Niemi UNISANTEN. Gross UNISANTET. Calandra CHUV LausanneS. Meylan Speaker CHUV Lausanne
P088
Methylene Blue shows an antiviral activity against hepatitis D virus in vitro
Poster (only) SSI
E. Tseligka Faculty of Medicine of GenevaS. Conzelmann Faculty of Medicine of GenevaA. Cerny Epatocentro TicinoT. Cerny Hospiz St.GallenE. Cerny Omni Drugs SAs. clement Speaker Faculty of Medicine of GenevaF. Negro Geneva University Hospital
P089
SOLAR 12-month results – randomized switch trial of CAB+RPV LA vs oral B/FTC/TAF
Poster (only) SSI
M. Ramgopal Midway Immunology and Research Center, Fort Pierce, FL, USAA. Castagna Vita-Salute University San Raffaele Scientific Institute, Milan, ItalyC. Cazanave University Hospital of Bordeaux, Bordeaux, FranceV. Diaz-Brito Parc Sanitari Sant Joan de Deu, Sant Boi de Llobregat, SpainR. Dretler Infectious Disease Specialists of Atlanta, Decatur, GA, USA; S. Oka National Center for Global Health and Medicine, Tokyo, JapanO. Osiyemi Triple O Research Institute PA, West Palm Beach, FL, USAK. Sutton ViiV Healthcare, Durham, NC, USAD. Sutherland-Phillips ViiV Healthcare, Durham, NCA. Berni GSKC. Latham ViiV Healthcare, Durham, NCF. Zhang GSK, Collegeville, PA, USAR. D’Amico ViiV Healthcare, Durham, NC, USAJ. van Wyk ViiV Healthcare, Brentford, UKP. Rhein Speaker ViiV Healthcare, Münchenbuchsee, Switzerland
P090
Spondylodiscitis and vascular graft infection due to Listeria monocytogenes, an unusual pathogen: case report and a review of the literature.
Poster (only) SSI
A. Sanzone Speaker Clinica Luganese Moncucco, LuganoN. Mezzasalma Clinica Luganese Moncucco, LuganoC. Zehnder Clinica Luganese Moncucco, LuganoE. LLESHI Synlab Suisse SAS. Schlunke Clinica Luganese MoncuccoA. Badaracco Clinica luganese moncuccoC. Garzoni Clinica Luganese Moncucco
P091
P092
Disseminated actinomycosis mimicking malignancy - a case report
Poster (only) SSI
S. Burgener Cantonal Hospital of FrauenfeldK. Herzog Thurgau Hospital GroupA. Kistler Cantonal Hospital of FrauenfeldR. Fulchini Speaker Cantonal Hospital of Münsterlingen
P093
Three-year B/F/TAF use in treatment-naïve (TN) and treatment-experienced (TE) PLWH in the BICSTaR study in Canada, France and Germany
Poster (only) SSI
S. Schellberg Novopraxis Berlin GbRP. Khaykin MainFachArztC. Wyen Praxis am EbertplatzJ. De Vet Spectrum HealthA. Wong Department of Medicine, University of SaskatchewanC. Duvivier Maladies Infectieuses Tropicales, Hop Necker Enfants MaladesO. Robineau University of Lille, Infectious Disease DepartmentB. Albuquerque Gilead Sciences GmbHS. Schreiber Gilead Sciences GmbHD. Thorpe Gilead Sciences Europe LtdM. Heinzkill Gilead Sciences GmbHS. Sahali Gilead Sciences, Inc.T. Saifi Gilead Sciences Canada, Inc.C. Oberle Speaker Gilead Sciences Switzerland SàrlT. Cassidy Gilead Sciences Europe LtdC. Spinner University Hospital Rechts der Isar, Department of Medicine II
P094
A systematic comparison of three cartridge-based platforms for syndromic testing of clinical samples for respiratory viruses
Poster (only) SSI
D. Mills Speaker Institute of Medical Virology, University of ZurichJ. Huder Institute of Medical Virology, University of ZurichG. Bloemberg Institute of Medical Virology, University of ZurichM. Huber Institute of Medical Virology, University of Zurich
P095
Invasive aspergillosis in an immunocompetent ICU patient with adenovirus associated pneumonia – a case report
Poster (only) SSI
A. Reusser Cantonal Hospital of FrauenfeldM. Moos Cantonal Hospital of FrauenfeldC. Weber Cantonal Hospital of FrauenfeldR. Gmuer Cantonal Hospital of FrauenfeldM. Stoeckli Cantonal Hospital of MünsterlingenB. Vrugt Cantonal Hospital of MünsterlingenK. Herzog Thurgau Hospital GroupR. Fulchini Speaker Cantonal Hospital of Münsterlingen
P096
P097
Intraabdominal Abscess with Clostridium Difficile; A Case Report.
Poster (only) SSI
L. Marquardt Speaker Kantonsspital Baden AGA. Friedl Kantonsspital Baden AG
P098
Case report: Nothing Ventured Nothing Gained - Desensitization to Hydroxychloroquine in a Case of Chronic Prosthetic Aortic Graft Infection with Coxiella burnetii
Poster (only) SSI
I. Schoepf Speaker Insel Gruppe AG, Inselspital, Universitätsspital BernA. Gschwend Insel Gruppe AG, Inselspital, Universitätsspital BernF. Schoenhoff Insel Gruppe AG, Inselspital, Universitätsspital BernC. Staehelin Insel Gruppe AG, Inselspital, Universitätsspital Bern
P099
Effectiveness of annual cantonal influenza campaign and vaccination in reducing influenza burden in nursing homes of Vaud
Poster (only) SSHH
P. Cuiña-Iglesias Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)L. Qalla-Widmer Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)C. Riccio Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)B. Sobgoui Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)F. Battistella Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)A. Cassini Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)M. Nahimana Tessemo Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)E. Glampedakis Speaker Unité cantonale Hygiène, Prévention et Contrôle de l’infection (HPCi - VD)
P100
Current state of infection prevention and control in long-term-care facilities in Eastern Switzerland: first results within the OSKAR (Ostschweizer Kompetenznetz für Infektionsprävention in Alters-und Pflegeheimen)-Project
Poster (only) SSHH
N. Bloch Speaker Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandF. Grässli Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandP. Kohler Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandJ. Kuhn Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandS. Kuster Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandM. Schlegel Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, SwitzerlandD. Flury Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland
P101
Nouveau protocole : surveillance de la consommation de Produit HydroAlcoolique
Poster (only) SSHH Best innovation
C. Riccio Speaker Unité cantonale HPCI Vaud E. Glampedakis Unité cantonale HPCI Vaud M. Nahimana-Tessemo Unité cantonale HPCI Vaud L. Qalla-Widmer Unité cantonale HPCI Vaud
P102
Vancomycin-resistant Enterococci surveillance in a surgical department: role of the infection prevention and control nurse
Poster (only) SSHH
I. Koenig Speaker CHUV Centre Hospitalier Universitaire Vaudois (CHUV)A. Jeffries CHUV Centre Hospitalier Universitaire Vaudois (CHUV)C. Granja Dubost CHUV Centre Hospitalier Universitaire Vaudois (CHUV)D. Blanc CHUV Centre Hospitalier Universitaire Vaudois (CHUV)L. Senn CHUV Centre Hospitalier Universitaire Vaudois (CHUV)
P103
P104
DOPPELSACKSYSTEM BEI WÄSCHE AUS KONTAKTISOLATIONEN – NOTWENIDIG?
Poster (only) SSHH
C. Gfeller Insel Gruppe AGT. Kaspar Insel Gruppe AGL. Damonti Insel Gruppe AGN. Marti Speaker Insel Gruppe AG
P105
The impact of the COVID - 19 pandemic on nosocomial bloodstream infection: a retrospective analysis
Poster (only) SSHH
S. Dietrich Speaker SRO Spital LangenthalA. Imhof Speaker SRO Spital Langenthal